<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04201704</url>
  </required_header>
  <id_info>
    <org_study_id>AAAR2083</org_study_id>
    <nct_id>NCT04201704</nct_id>
  </id_info>
  <brief_title>Effect of Giving Reduced Fluid in Children After Trauma</brief_title>
  <official_title>Effect of Restricted Fluid Management Strategy on Outcomes in Critically Ill Pediatric Trauma Patients: A Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Childress Institute for Pediatric Trauma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to help decide how much intravenous (IV) fluid should be given to
      pediatric trauma patients. No standard currently exists for managing fluids in critically ill
      pediatric trauma patients, and many fluid strategies are now in practice. For decades, trauma
      patients got high volumes of IV fluid. Recent studies in adults show that patients actually
      do better by giving less fluid. The investigators do not know if this is true in children and
      this study is designed to answer that question and provide guidelines for IV fluid management
      in children after trauma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aggressive fluid resuscitation has been the cornerstone of early post-operative and trauma
      management for decades. However, recent prospective adult studies have challenged this
      practice, linking high volume crystalloid resuscitation to increased mortality,
      cardiopulmonary, gastrointestinal and hematologic complications. A retrospective study the
      investigators recently performed at their quaternary-care children's hospital echoed these
      results. High quality prospective data is necessary to determine best practice guidelines in
      our pediatric surgery and trauma patients.

      Currently, no standard exists to guide management of crystalloid fluid administration in
      trauma patients. Both liberal and restricted strategies are in use, dependent on physician
      discretion. The investigators propose the first randomized controlled trial (RCT) comparing a
      liberal to a restricted fluid management strategy in critically ill pediatric trauma
      patients. The objective of this comparative effectiveness study is to conduct a multicenter
      (around 10 sites) randomized controlled trial (RCT) to determine whether liberal or
      restricted fluid administration leads to better outcomes in these patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 27, 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall complications</measure>
    <time_frame>Up to time of discharge (up to approximately 1 month)</time_frame>
    <description>Total number of complications defined as pulmonary edema, hemorrhage, deep cavity infection, anastomotic dehiscence, thrombosis, death, superficial wound infection, ileus, and pneumonia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Hours of Hospital Length of Stay</measure>
    <time_frame>Up to time of discharge (up to approximately 1 month)</time_frame>
    <description>length of time in hospital to inpatient discharge in hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Hours of ICU Length of Stay</measure>
    <time_frame>Up to time of discharge (up to approximately 1 month)</time_frame>
    <description>length of time in pediatric intensive care unit in hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hours on Supplemental Oxygen</measure>
    <time_frame>Up to time of discharge (up to approximately 1 month)</time_frame>
    <description>length of time patient requires non-invasive supplemental O2 in hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Hours on Ventilator</measure>
    <time_frame>Up to time of discharge (up to approximately 1 month)</time_frame>
    <description>length of time patient requires invasive ventilation in hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Critical Illness</condition>
  <condition>Pediatrics</condition>
  <condition>General Surgery</condition>
  <condition>Fluid Therapy</condition>
  <condition>Wounds and Injuries</condition>
  <arm_group>
    <arm_group_label>Liberal IV Fluid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Maintenance fluid rate calculated by 4-2-1 formula for patients &lt;110kg: 4 mL/kg for first 0-10kg + 2 mL/kg for 11-20kg + 1 mL/kg for each kg &gt;20kg
Patients &gt;110kg maintenance 150 mL/hr
Bolus Criteria: change in 1 of: &gt;20% decrease in systolic blood pressure 50th percentile for age and sex, &gt;20% increase in heart rate over 50th percentile for age, base excess &gt; -5mmol/L, blood lactate &gt;2mmol/L, AND urine output (UO) &lt;1 mL/kg/hr if &lt;50kg or &lt;50 mL/hr if &gt;50kg
If criteria met: bolus 20 mL/kg if &lt;50kg or 1 L if ≥50 kg
For transfusion: give 10 mL/kg packed red blood cells, platelets, or fresh frozen plasma up to 250 mL. If &gt;25kg give 250 mL.
Diuresis- after minimum 24hrs: if UO &lt;2 mL/kg/hr (or &lt;100 mL/hr if &gt;50 kg) continue maintenance rate and bolus per initial phase. If UO &gt;2 mL/kg/hr (or &gt;100 mL/hr if &gt;50kg), and lactate, systolic blood pressure, heart rate, creatinine are normal then lower IV fluid rate to ½ maintenance rate and then to &quot;keep vein open&quot; once on regular feeds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restricted IV Fluid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maintenance fluid rate calculated by 70% of 4-2-1 formula if &lt;110 kg: 4 mL/kg for first 0-10 kg, + 2 mL/kg for 11-20 kg, + 1 mL/kg for every kg &gt;20 kg
Patients &gt;110 kg: maintenance is 105 mL/hr
If same bolus criteria met: 10 mL/kg for patients &lt;50kg, or 500 mL if ≥50 kg
If meet transfusion criteria: transfuse 10 mL/kg with packed red blood cells, platelets, or fresh frozen plasma by weight up to 250 mL. Patients &gt;25 kg get 250 mL per transfusion
Diuresis (after minimum 24 hrs): if UO &lt;1 mL/kg/hr (or &lt;50 mL/hr if &gt;50 kg) then continue IV fluids at maintenance rate and bolus as needed. If UO 1‐2 mL/kg/hr (or 50-100 mL/hr if &gt;50 kg) then decrease IV rate to ½ maintenance rate. If UO &gt;2 mL/kg/hr (or &gt;100 mL/hr if &gt;50 kg), and Lactate, systolic blood pressure, heart rate, creatinine normal then reduce to &quot;keep vein open&quot; and consider Furosemide for goal UO &gt;2‐4 mL/kg/hr (100-200 mL/hr if &gt;50 kg) until euvolemic</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Balanced crystalloid solution volume administration</intervention_name>
    <description>Maintenance and bolus fluid volumes of balanced isotonic crystalloid solution administered based on arm.</description>
    <arm_group_label>Liberal IV Fluid</arm_group_label>
    <arm_group_label>Restricted IV Fluid</arm_group_label>
    <other_name>lactated ringers</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Packed Erythrocytes Units, Blood Product Unit volume</intervention_name>
    <description>For patients designated as Bleeding, where hemoglobin &lt;7 then patient will be transfused 10 mL/kg up to 250 mL/transfusion. If patient is hypovolemic with clinician discretion transfuse 20 mL/kg.</description>
    <arm_group_label>Liberal IV Fluid</arm_group_label>
    <arm_group_label>Restricted IV Fluid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Plasma volume</intervention_name>
    <description>For patients designated as Bleeding, where International Normalized Ratio (INR) &gt; 1.5 then patient will be transfused 10 mL/kg up to 250 mL/transfusion. If patient is hypovolemic with clinician discretion transfuse 20 mL/kg.</description>
    <arm_group_label>Liberal IV Fluid</arm_group_label>
    <arm_group_label>Restricted IV Fluid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Platelets volume</intervention_name>
    <description>For patients designated as Bleeding, where platelets &lt; 50,000 then patient will be transfused 10 mL/kg up to 250 mL/transfusion. If patient is hypovolemic with clinician discretion transfuse 20 mL/kg.</description>
    <arm_group_label>Liberal IV Fluid</arm_group_label>
    <arm_group_label>Restricted IV Fluid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Trauma patients older than 6 months and younger than 15 years admitted to the
             pediatric intensive care unit (PICU)

          -  Patients admitted to the PICU directly from the Emergency Department (ED)

          -  Patients admitted to the PICU from the operating room (OR)

          -  Patients transferred to PICU from outside facility ED (need to have been in ED 12
             hours or less)

        Exclusion Criteria:

          -  Patients transferred to PICU from outside PICU or inpatient floor

          -  Patients transferred to PICU from outside facility ED if &gt;12 hours

          -  Patients expected to be discharged from the PICU within 24 hours

          -  Patient with congenital heart disease as defined by a congenital cardiac defect
             requiring surgery or medication

          -  Patient with diagnosis of chronic cardiac condition (e.g. hypertension, cardiac
             arrhythmia)

          -  Patients with chronic kidney disease as defined by an abnormality of kidney structure
             or function, present for more than 3 months, with implications to health

          -  Post-operative transplant, cardiac, and neurosurgical patients

          -  Patients with traumatic brain injury

          -  Patients with any disease that may affect baseline blood pressure and heart rate
             (endocrine disorders, certain genetic disorders, mitochondrial diseases)

          -  Hypotension requiring vasopressor therapy

          -  If massive transfusion protocol initiated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent P Duron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincent P Duron, MD</last_name>
    <phone>212-342-8586</phone>
    <email>vd2312@cumc.columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Johns Hopkins University Charlotte R. Bloomberg Children's Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Barbara Wawryszyn, RN MSN CCRP</last_name>
      <phone>410-955-3429</phone>
      <email>bwawrys1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Irving Medical Center NewYork-Presbyterian Morgan Stanley Children's Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent P Duron, MD</last_name>
      <phone>212-342-8586</phone>
      <email>vd2312@cumc.columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwell Health Cohen Children's Medical Center</name>
      <address>
        <city>Queens</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Prince, MD</last_name>
      <phone>718-470-3636</phone>
      <email>JPrince@northwell.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994 Oct 27;331(17):1105-9.</citation>
    <PMID>7935634</PMID>
  </reference>
  <reference>
    <citation>Arikan AA, Zappitelli M, Goldstein SL, Naipaul A, Jefferson LS, Loftis LL. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med. 2012 May;13(3):253-8. doi: 10.1097/PCC.0b013e31822882a3.</citation>
    <PMID>21760565</PMID>
  </reference>
  <reference>
    <citation>Bouchard JE, Mehta RL. Fluid balance issues in the critically ill patient. Contrib Nephrol. 2010;164:69-78. doi: 10.1159/000313722. Epub 2010 Apr 20. Review.</citation>
    <PMID>20427995</PMID>
  </reference>
  <reference>
    <citation>Coons BE, Tam S, Rubsam J, Stylianos S, Duron V. High volume crystalloid resuscitation adversely affects pediatric trauma patients. J Pediatr Surg. 2018 Nov;53(11):2202-2208. doi: 10.1016/j.jpedsurg.2018.07.009. Epub 2018 Jul 24.</citation>
    <PMID>30072215</PMID>
  </reference>
  <reference>
    <citation>Cotton BA, Guy JS, Morris JA Jr, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock. 2006 Aug;26(2):115-21. Review.</citation>
    <PMID>16878017</PMID>
  </reference>
  <reference>
    <citation>Feinman M, Cotton BA, Haut ER. Optimal fluid resuscitation in trauma: type, timing, and total. Curr Opin Crit Care. 2014 Aug;20(4):366-72. doi: 10.1097/MCC.0000000000000104. Review.</citation>
    <PMID>24979715</PMID>
  </reference>
  <reference>
    <citation>Fletcher JJ, Bergman K, Blostein PA, Kramer AH. Fluid balance, complications, and brain tissue oxygen tension monitoring following severe traumatic brain injury. Neurocrit Care. 2010 Aug;13(1):47-56. doi: 10.1007/s12028-010-9345-2.</citation>
    <PMID>20376708</PMID>
  </reference>
  <reference>
    <citation>Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML, Rogers K, Reid C, Tanner AJ, Easley KA. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004 Aug;32(8):1771-6.</citation>
    <PMID>15286557</PMID>
  </reference>
  <reference>
    <citation>Kasotakis G, Sideris A, Yang Y, de Moya M, Alam H, King DR, Tompkins R, Velmahos G; Inflammation and Host Response to Injury Investigators. Aggressive early crystalloid resuscitation adversely affects outcomes in adult blunt trauma patients: an analysis of the Glue Grant database. J Trauma Acute Care Surg. 2013 May;74(5):1215-21; discussion 1221-2. doi: 10.1097/TA.0b013e3182826e13.</citation>
    <PMID>23609270</PMID>
  </reference>
  <reference>
    <citation>Klein MB, Hayden D, Elson C, Nathens AB, Gamelli RL, Gibran NS, Herndon DN, Arnoldo B, Silver G, Schoenfeld D, Tompkins RG. The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg. 2007 Apr;245(4):622-8.</citation>
    <PMID>17414612</PMID>
  </reference>
  <reference>
    <citation>Ley EJ, Clond MA, Srour MK, Barnajian M, Mirocha J, Margulies DR, Salim A. Emergency department crystalloid resuscitation of 1.5 L or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma. 2011 Feb;70(2):398-400. doi: 10.1097/TA.0b013e318208f99b.</citation>
    <PMID>21307740</PMID>
  </reference>
  <reference>
    <citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006 Jun 15;354(24):2564-75. Epub 2006 May 21.</citation>
    <PMID>16714767</PMID>
  </reference>
  <reference>
    <citation>Owens TM, Watson WC, Prough DS, Uchida T, Kramer GC. Limiting initial resuscitation of uncontrolled hemorrhage reduces internal bleeding and subsequent volume requirements. J Trauma. 1995 Aug;39(2):200-7; discussion 208-9.</citation>
    <PMID>7674386</PMID>
  </reference>
  <reference>
    <citation>Takil A, Eti Z, Irmak P, Yilmaz Göğüş F. Early postoperative respiratory acidosis after large intravascular volume infusion of lactated ringer's solution during major spine surgery. Anesth Analg. 2002 Aug;95(2):294-8, table of contents.</citation>
    <PMID>12145036</PMID>
  </reference>
  <reference>
    <citation>Watters JM, Tieu BH, Todd SR, Jackson T, Muller PJ, Malinoski D, Schreiber MA. Fluid resuscitation increases inflammatory gene transcription after traumatic injury. J Trauma. 2006 Aug;61(2):300-8; discussion 308-9.</citation>
    <PMID>16917442</PMID>
  </reference>
  <reference>
    <citation>Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003 Jul 19;362(9379):192-7. Erratum in: Lancet. 2006 Mar 18;367(9514):902. Erratum in: Lancet. 2006 Mar 18;367(9514):897; author reply 900-2.</citation>
    <PMID>12885479</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2019</study_first_posted>
  <last_update_submitted>December 14, 2019</last_update_submitted>
  <last_update_submitted_qc>December 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Vincent Duron</investigator_full_name>
    <investigator_title>Assistant Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>Fluid Therapy</keyword>
  <keyword>Intensive Care Units, Pediatric</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Wounds and Injuries</keyword>
  <keyword>Multiple Trauma</keyword>
  <keyword>Treatment Outcome</keyword>
  <keyword>Postoperative Complications</keyword>
  <keyword>Resuscitation</keyword>
  <keyword>Hemodynamics</keyword>
  <keyword>Infusions, Intravenous</keyword>
  <keyword>Isotonic Solutions</keyword>
  <keyword>Crystalloid Solutions</keyword>
  <keyword>Diuretics</keyword>
  <keyword>Organism Hydration Status</keyword>
  <keyword>Body Water</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

